Neurocrine Bioscience buy Needham & Company LLC
Start price
15.04.25
/
50%
€86.30
Target price
15.04.26
€121.87
Performance (%)
27.81%
End price
16.04.26
€110.30
Summary
This prediction ended on 16.04.26 with a price of €110.30. The BUY prediction by Needham___Company_LL finished with a performance of 27.81%. Needham___Company_LL has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 0.629% | 0.629% | 25.729% |
| iShares Core DAX® | 0.411% | 8.821% | 12.264% |
| iShares Nasdaq 100 | 3.678% | 10.820% | 44.017% |
| iShares Nikkei 225® | 2.701% | 15.247% | 48.041% |
| iShares S&P 500 | 2.445% | 7.933% | 32.998% |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $138.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
-2.05%
13:16
13:16
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.60
06.04.26
06.04.26
€160.60
06.04.27
06.04.27
-2.73%
13:16
13:16
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.40
22.09.25
22.09.25
€144.89
22.09.26
22.09.26
-11.54%
13:16
13:16